GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026
GlobeImmune Market Cap
GlobeImmune has a market cap or net worth of $575 as of January 23, 2026. Its market cap has decreased by -99.97% in one year.
Market Cap
575.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 2, 2014, GlobeImmune's market cap has decreased from 60.99M to 575.00, a decrease of -100.00%. That is a compound annual growth rate of -63.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 575.00 | - |
| Dec 31, 2025 | 575.00 | 9,483.33% |
| Dec 12, 2024 | 6.00 | -99.85% |
| Dec 30, 2022 | 4.03K | 600.17% |
| Dec 31, 2021 | 575.00 | -99.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adhera Therapeutics | 1.16K |
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Eloxx Pharmaceuticals | 330.00 |